retatrutide alternative Weight Loss Blog – Maryland Trim Clinic Retatrutide Surpasses Zepbound in Weight

Guttenplan KA, Stafford BK, El-Danaf RN, et al

Here, we used the US Department of Veterans Affairs databases to build a cohort of people with diabetes who initiated GLP-1RA ( n = 215,970) and compared them to those who initiated sulfonylureas ( n = 159,465), dipeptidyl peptidase 4 (DPP4) inhibitors ( n = 117,989) or sodiumglucose cotransporter-2 (SGLT2) inhibitors ( n = 258,614), a control group composed of an equal proportion of individuals initiating sulfonylureas, DPP4 inhibitors and SGLT2 inhibitors ( n = 536,068), and a control group of 1,203,097 individuals who continued use of non-GLP-1RA antihyperglycemics (usual care)

A 2024 observational study raised questions about whether GLP-1 receptor agonists as a class may be associated with an increased risk of GORD-related conditions

Always verify current pricing directly with pharmacies and manufacturers